Cover Image
市場調查報告書

EpiCast Report:失眠症的流行病學的預測(∼2023年)

EpiCast Report: Insomnia - Epidemiology Forecast to 2023

出版商 GlobalData 商品編碼 325392
出版日期 內容資訊 英文 67 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:失眠症的流行病學的預測(∼2023年) EpiCast Report: Insomnia - Epidemiology Forecast to 2023
出版日期: 2015年02月03日 內容資訊: 英文 67 Pages
簡介

全球主要7個國家的失眠症患者總數,2013年為121,799,911人,預計2023年達到130,482,156人。還有在此期間的患病人數的年複合成長率推算為0.71%。在詳細不同症狀上,慢性失眠症的患者(不滿DSM-IV標準的人),從2013年的62,982,390人,預計2023年達到67,471,957人。慢性原發性失眠症的患者數,從2013年的23,690,040人,預計2023年成為25,378,728,還有慢性次發性失眠症的患者數,從2013年的53,697,425人,預計2023年也達到57,525,122人。如上所述,非常多人患失眠症,一般認為全球總人口的1/3有某種失眠症的症狀。

本報告提供全球主要國家的失眠症的發病情形與今後預測相關分析、疾病的特徵,及目前患病者的發病情形、今後10年的患病數量的預測值等調查評估。

第1章 目錄

第2章 簡介

  • 分析的背景情況
  • 相關報告
  • 出版預定的相關調查報告

第3章 流行病學

  • 疾病的背景
  • 危險因素和共生病症
  • 全球趨勢
  • 預測手法
    • 利用之資訊來源
    • 未利用之資訊來源
    • 預測的前提條件與手法
  • 急性失眠症的流行病學的預測(今後11年份)
    • 急性失眠症的患病者總數
    • 急性失眠症的患病者總數:各年齡
    • 急性失眠症的患病者總數:男女
    • 急性失眠症的患病者總數(已調整年齡)
  • 慢性失眠症(未滿足DSM- IV標準的人)的流行病學的預測(今後11年份)
    • 慢性失眠症(未滿足DSM- IV標準的人)的患病者總數
    • 慢性失眠症(未滿足DSM- IV標準的人)的患病者總數:各年齡
    • 慢性失眠症(未滿足DSM- IV標準的人)的患病者總數:男女
    • 慢性失眠症(未滿足DSM- IV標準的人)的患病者總數(已調整年齡)
  • 慢性原發性失眠症的流行病學的預測(今後11年份)
    • 慢性原發性失眠症的患病者總數
    • 慢性原發性失眠症的患病者總數:各年齡
    • 慢性原發性失眠症的患病者總數:男女
    • 慢性原發性失眠症的患病者總數(已調整年齡)
  • 慢性次發性失眠症的流行病學的預測(今後11年份)
    • 慢性次發性失眠症的患病者總數
    • 慢性次發性失眠症的患病者總數:各年度
    • 慢性次發性失眠症的患病者總數:男女
    • 慢性次發性失眠症的患病者總數(已調整年齡)
  • 討論
    • 流行病學預測相關考察
    • 分析的限制
    • 分析的優勢

第4章 附錄

目錄
Product Code: GDHCER075-15

GlobalData epidemiologists forecast that the total prevalent cases of acute insomnia in the 7MM will increase from 121,799,911 total prevalent cases in 2013, to 130,482,156 total prevalent cases in 2023 at an Annual Growth Rate (AGR) of 0.71%. GlobalData epidemiologists forecast an increase in the total prevalent cases of chronic insomnia (not fulfilling DSM-IV criteria) in the 7MM from 62,982,390 total prevalent cases in 2013, to 67,471,957 total prevalent cases in 2023 at an AGR of 0.71%. The 7MM had an estimated 23,690,040 total prevalent cases of chronic primary insomnia in 2013 and the number of total prevalent cases is expected to increase to 25,378,728 by 2023, at an AGR of 0.71%. GlobalData epidemiologists forecast that the total prevalent cases of chronic secondary insomnia in the 7MM will increase from 53,697,425 total prevalent cases in 2013, to 57,525,122 total prevalent cases in 2023 at an AGR of 0.71%.

Insomnia is a highly prevalent condition; approximately one third of the general population presents with some degree of insomnia.

GlobalData epidemiologists used comprehensive country-specific data from population-based studies published in peer-reviewed journal articles to arrive at a meaningful, in-depth analysis and forecast for the total prevalent cases of acute insomnia, chronic insomnia (not fulfilling DSM-IV criteria), chronic primary insomnia, and chronic secondary insomnia in the 7MM, based on the DSM-IV criteria. For all the 7MM, the total prevalent cases of acute insomnia, chronic insomnia (not fulfilling DSM-IV criteria), chronic primary insomnia, and chronic secondary insomnia were segmented by age and sex, which facilitates an understanding of the distribution of the disease within the population and informs strategies to improve the management of the disease. Furthermore, the forecast methodology is consistent across each of the 7MM, thereby allowing for a meaningful comparison of the forecast total prevalent cases among each market.

Scope

  • The Insomnia EpiCast Report providess an overview of the risk factors, comorbidities, and the global and historical trends for insomnia in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total prevalent cases of acute insomnia, chronic insomnia (not fulfilling DSM-IV criteria), chronic primary insomnia, and chronic secondary insomnia, segmented by sex and age (in 15-year age groups beginning at 15 years and ending at =75 years) in these markets.
  • The insomnia epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

  • Develop business strategies by understanding the trends shaping and driving the global insomnia market.
  • Quantify patient populations in the global insomnia market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities for insomnia therapeutics in each of the markets covered.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Epidemiology

  • 3.1. Disease Background
  • 3.2. Risk Factors and Comorbidities
  • 3.3. Global Trends
  • 3.4. Forecast Methodology
    • 3.4.1. Sources Used
    • 3.4.2. Sources Not Used
    • 3.4.3. Forecast Assumptions and Methods
  • 3.5. Epidemiological Forecast for Acute Insomnia (2013-2023)
    • 3.5.1. Total Prevalent Cases of Acute Insomnia
    • 3.5.2. Age-Specific Total Prevalent Cases of Acute Insomnia
    • 3.5.3. Sex-Specific Total Prevalent Cases of Acute Insomnia
    • 3.5.4. Age-Standardized Total Prevalence of Acute Insomnia
  • 3.6. Epidemiological Forecast for Chronic Insomnia (Not Fulfilling DSM-IV Criteria) (2013-2023)
    • 3.6.1. Total Prevalent Cases of Chronic Insomnia (Not Fulfilling DSM-IV Criteria)
    • 3.6.2. Age-Specific Total Prevalent Cases of Chronic Insomnia (Not Fulfilling DSM-IV Criteria)
    • 3.6.3. Sex-Specific Total Prevalent Cases of Chronic Insomnia (Not Fulfilling DSM-IV Criteria)
    • 3.6.4. Age-Standardized Total Prevalent Cases of Chronic Insomnia (Not Fulfilling DSM-IV Criteria)
  • 3.7. Epidemiological Forecast for Chronic Primary Insomnia (2013-2023)
    • 3.7.1. Total Prevalent Cases of Chronic Primary Insomnia
    • 3.7.2. Age-Specific Total Prevalent Cases of Chronic Primary Insomnia
    • 3.7.3. Sex-Specific Total Prevalent Cases of Chronic Primary Insomnia
    • 3.7.4. Age-Standardized Total Prevalence of Chronic Primary Insomnia
  • 3.8. Epidemiological Forecast for Chronic Secondary Insomnia (2013-2023)
    • 3.8.1. Total Prevalent Cases of Chronic Secondary Insomnia
    • 3.8.2. Age-Specific Total Prevalent Cases of Chronic Secondary Insomnia
    • 3.8.3. Sex-Specific Total Prevalent Cases of Chronic Secondary Insomnia
    • 3.8.4. Age-Standardized Total Prevalence of Chronic Secondary Insomnia
  • 3.9. Discussion
    • 3.9.1. Epidemiological Forecast Insight
    • 3.9.2. Limitations of the Analysis
    • 3.9.3. Strengths of the Analysis

4. Appendix

  • 4.1. Bibliography
  • 4.2. About the Authors
    • 4.2.1. Epidemiologists
    • 4.2.2. Reviewers
    • 4.2.3. Global Director of Therapy Analysis and Epidemiology
    • 4.2.4. Global Head of Healthcare
  • 4.3. About GlobalData
  • 4.4. About EpiCast
  • 4.5. Disclaimer

List of Tables

  • Table 1: Risk Factors and Comorbidities for Insomnia
  • Table 2: DSM-IV Diagnostic Criteria for Primary Insomnia
  • Table 3: Sources of Epidemiological Data Used for the Forecast for Total Prevalent Cases of Acute Insomnia in the 7MM
  • Table 4: Sources of Epidemiological Data Used for the Forecast for Total Prevalent Cases of Chronic Insomnia (Not Fulfilling DSM-IV Criteria) in the 7MM
  • Table 5: Sources of Epidemiological Data Used for the Forecast for Total Prevalent Cases of Chronic Primary Insomnia in the 7MM
  • Table 6: Sources of Epidemiological Data Used for the Forecast for Total Prevalent Cases of Chronic Secondary Insomnia in the 7MM
  • Table 7: 7MM, Total Prevalent Cases of Acute Insomnia, Both Sexes, Ages ≥15 Years, N, Select Years 2013-2023
  • Table 8: 7MM, Age-Specific Total Prevalent Cases of Acute Insomnia, Both Sexes, N (Row %), 2013
  • Table 9: 7MM, Sex-Specific Total Prevalent Cases of Acute Insomnia, Ages ≥15 Years, N (Row %), 2013
  • Table 10: 7MM, Total Prevalent Cases of Chronic Insomnia (Not Fulfilling DSM-IV Criteria), Both Sexes, Ages ≥15 Years, N, Select Years 2013-2023
  • Table 11: 7MM, Age-Specific Total Prevalent Cases of Chronic Insomnia (Not Fulfilling DSM-IV Criteria), Both Sexes, N (Row %), 2013
  • Table 12: 7MM, Sex-Specific Total Prevalent Cases of Chronic Insomnia (Not Fulfilling DSM-IV Criteria), Ages ≥15 Years, N (Row %), 2013
  • Table 13: 7MM, Total Prevalent Cases of Chronic Primary Insomnia, Both Sexes, Ages ≥15 Years, N, Select Years 2013-2023
  • Table 14: 7MM, Age-Specific Total Prevalent Cases of Chronic Primary Insomnia, Both Sexes, N (Row %), 2013
  • Table 15: 7MM, Sex-Specific Total Prevalent Cases of Chronic Primary Insomnia, Ages ≥15 Years, N (Row %), 2013
  • Table 16: 7MM, Total Prevalent Cases of Chronic Secondary Insomnia, Both Sexes, Ages ≥15 Years, N, 2013-2023
  • Table 17: 7MM, Age-Specific Total Prevalent Cases of Chronic Secondary Insomnia, Both Sexes, N (Row %), 2013
  • Table 18: 7MM, Sex-Specific Total Prevalent Cases of Chronic Secondary Insomnia, Ages ≥15 Years, N (Row %), 2013

List of Figures

  • Figure 1: Global Average of the Total Prevalence of Insomnia Symptoms and Diagnoses
  • Figure 2: Patient Flow for the Epidemiological Forecast of Insomnia in the 7MM
  • Figure 3: 7MM, Total Prevalent Cases of Acute Insomnia, Both Sexes, Ages ≥15 Years, N, 2013-2023
  • Figure 4: 7MM, Age-Specific Total Prevalent Cases of Acute Insomnia, Both Sexes, N, 2013
  • Figure 5: 7MM, Sex-Specific Total Prevalent Cases of Acute Insomnia, Ages ≥15 Years, N, 2013
  • Figure 6: 7MM, Age-Standardized Total Prevalence of Acute Insomnia (%), Ages ≥15 Years, by Sex, 2013
  • Figure 7: 7MM, Total Prevalent Cases of Chronic Insomnia (Not Fulfilling DSM-IV Criteria), Both Sexes, Ages ≥15 Years, N, 2013-2023
  • Figure 8: 7MM, Age-Specific Total Prevalent Cases of Chronic Insomnia (Not Fulfilling DSM-IV Criteria), Both Sexes, Ages ≥15 Years, N, 2013
  • Figure 9: 7MM, Sex-Specific Total Prevalent Cases of Chronic Insomnia (Not Fulfilling DSM-IV Criteria), Ages ≥15 Years, N, 2013
  • Figure 10: 7MM, Age-Standardized Total Prevalence of Chronic Insomnia (Not Fulfilling DSM-IV Criteria) (%), Ages ≥15 Years, by Sex, 2013
  • Figure 11: 7MM, Total Prevalent Cases of Chronic Primary Insomnia, Both Sexes, Ages ≥15 Years, N, 2013-2023
  • Figure 12: 7MM, Age-Specific Total Prevalent Cases of Chronic Primary Insomnia, Both Sexes, N, 2013
  • Figure 13: 7MM, Sex-Specific Total Prevalent Cases of Chronic Primary Insomnia, Ages ≥15 Years, N, 2013
  • Figure 14: 7MM, Age-Standardized Total Prevalence of Chronic Primary Insomnia (%), Ages ≥15 Years, by Sex, 2013
  • Figure 15: 7MM, Total Prevalent Cases of Chronic Secondary Insomnia, Both Sexes, Ages ≥15 Years, N, 2013-2023
  • Figure 16: 7MM, Age-Specific Total Prevalent Cases of Chronic Secondary Insomnia, Both Sexes, N, 2013
  • Figure 17: 7MM, Sex-Specific Total Prevalent Cases of Chronic Secondary Insomnia, Ages ≥15 Years, N, 2013
  • Figure 18: 7MM, Age-Standardized Total Prevalence of Chronic Secondary Insomnia (%), Ages ≥15 Years, by Sex, 2013
Back to Top